KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Tax Provisions (2016 - 2025)

Idexx Laboratories has reported Tax Provisions over the past 17 years, most recently at $58.8 million for Q4 2025.

  • Quarterly results put Tax Provisions at $58.8 million for Q4 2025, up 46.12% from a year ago — trailing twelve months through Dec 2025 was $264.7 million (up 19.26% YoY), and the annual figure for FY2025 was $264.7 million, up 19.26%.
  • Tax Provisions for Q4 2025 was $58.8 million at Idexx Laboratories, down from $70.2 million in the prior quarter.
  • Over the last five years, Tax Provisions for IDXX hit a ceiling of $70.2 million in Q3 2025 and a floor of $29.1 million in Q4 2021.
  • Median Tax Provisions over the past 5 years was $53.4 million (2022), compared with a mean of $52.1 million.
  • Biggest five-year swings in Tax Provisions: soared 1074.82% in 2021 and later dropped 20.4% in 2022.
  • Idexx Laboratories' Tax Provisions stood at $29.1 million in 2021, then surged by 40.86% to $41.0 million in 2022, then increased by 10.09% to $45.1 million in 2023, then fell by 10.87% to $40.2 million in 2024, then skyrocketed by 46.12% to $58.8 million in 2025.
  • The last three reported values for Tax Provisions were $58.8 million (Q4 2025), $70.2 million (Q3 2025), and $68.4 million (Q2 2025) per Business Quant data.